繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

bioAffinity将实施1比30反向股票分割

2025-09-17 20:32

  • bioAffinity Technologies (NASDAQ:BIAF) plans to execute a 1-for-30 reverse split of its common stock to bring itself into compliance with Nasdaq’s minimum bid price requirement.
  • Commencing with the opening of trading on the Nasdaq Capital Market on Sept. 19, 2025, the company’s common stock will trade on a post-split basis under the symbol BIAF.
  • BIAF --16.7% premarket to $0.2174
  • Source: Press Release

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。